Australia markets close in 3 hours 28 minutes

Cynata Therapeutics Limited (CYP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1400+0.0150 (+12.00%)
As of 12:20PM AEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
5,920
12,394
8,825
3,778
5,920
Selling general and administrative
3,232
3,232
4,060
4,494
2,940
Total operating expenses
16,543
16,543
13,838
9,080
10,512
Operating income or loss
-16,543
-16,543
-13,838
-9,080
-10,512
Total other income/expenses net
1,912
1,912
8,328
1,298
6,731
Income before tax
-14,277
-14,277
-5,445
-7,690
-3,639
Income tax expense
0
0
0
0
0
Income from continuing operations
-14,277
-14,277
-5,445
-7,690
-3,639
Net income
-14,277
-14,277
-5,445
-7,690
-3,639
Net income available to common shareholders
-14,277
-14,277
-5,445
-7,690
-3,639
Basic EPS
-
-0.10
-0.04
-0.06
-0.03
Diluted EPS
-
-0.10
-0.04
-0.06
-0.03
Basic average shares
-
145,092
143,277
130,427
104,822
Diluted average shares
-
145,092
143,277
130,427
104,822